Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Sprague, Stuart

One or more keywords matched the following items that are connected to Sprague, Stuart

Item Type	Name
Concept	Renal Dialysis
Concept	Peritoneal Dialysis
Concept	Peritoneal Dialysis, Continuous Ambulatory
Academic Article	Advanced glycation of beta 2-microglobulin in the pathogenesis of bone lesions in dialysis-associated amyloidosis.
Academic Article	Serum amyloid P component: a predictor of clinical beta 2-microglobulin amyloidosis.
Academic Article	Safety and efficacy of long-term treatment of secondary hyperparathyroidism by low-dose intravenous calcitriol.
Academic Article	Effect of a low calcium dialysate on parathyroid hormone secretion in diabetic patients on maintenance hemodialysis.
Academic Article	Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol.
Academic Article	The pathogenesis of beta(2)-microglobulin-induced bone lesions in dialysis-related amyloidosis.
Academic Article	The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism.
Academic Article	Dialysis-related amyloidosis.
Academic Article	Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings.
Academic Article	Assessment of the stability of an immunoadsorbent for the extracorporeal removal of Beta-2-microglobulin from blood.
Academic Article	Mortality risk among hemodialysis patients receiving different vitamin D analogs.
Academic Article	Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial.
Academic Article	Lanthanum carbonate vs. sevelamer hydrochloride for the reduction of serum phosphorus in hemodialysis patients: a crossover study.
Academic Article	When is Vitamin D contraindicated in dialysis patients?
Academic Article	Which of the K/DOQI guidelines for bone disease in dialysis patients should be changed?
Academic Article	Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients.
Academic Article	Beta2-microglobulin stimulates osteoclast formation.
Academic Article	Control of secondary hyperparathyroidism by vitamin D receptor agonists in chronic kidney disease.
Academic Article	Relationship of aluminum to neurocognitive dysfunction in chronic dialysis patients.
Academic Article	Hypocalcemia in end-stage renal disease: a consequence of spontaneous parathyroid gland infarction.
Academic Article	Maintenance of bone mass in patients receiving dialytic therapy.
Academic Article	Simultaneous control of PTH and CaxP Is sustained over three years of treatment with cinacalcet HCl.
Academic Article	KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).
Academic Article	Factors affecting tissue aluminum concentration.
Academic Article	Is bone mineral density measurement of any value in a dialysis patient?
Academic Article	Determinants of tissue aluminum concentration.
Academic Article	Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
Academic Article	Higher strength lanthanum carbonate provides serum phosphorus control with a low tablet burden and is preferred by patients and physicians: a multicenter study.
Academic Article	Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patients.
Academic Article	Is beta 2-microglobulin a mediator of bone disease?
Academic Article	Aluminum neurotoxicity: a reevaluation.
Academic Article	Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity.
Academic Article	Oral doxercalciferol therapy for secondary hyperparathyroidism in a peritoneal dialysis patient.
Academic Article	Pharmacokinetics of icodextrin in peritoneal dialysis patients.
Academic Article	Painful skin ulcers in a hemodialysis patient.
Academic Article	A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients.
Academic Article	Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients.
Academic Article	Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism.
Academic Article	A Randomized Trial of Cinacalcet versus Vitamin D Analogs as Monotherapy in Secondary Hyperparathyroidism (PARADIGM).
Academic Article	Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.
Academic Article	Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients.
Academic Article	Iron-related parameters in dialysis patients treated with sucroferric oxyhydroxide.
Academic Article	One-year efficacy and safety of the iron-based phosphate binder sucroferric oxyhydroxide in patients on peritoneal dialysis.
Academic Article	Real-world effectiveness of sucroferric oxyhydroxide in patients on chronic hemodialysis: A retrospective analysis of pharmacy data?.
Academic Article	Sucroferric oxyhydroxide for the treatment of hyperphosphatemia.
Academic Article	Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients.
Academic Article	Long-term efficacy and safety of sucroferric oxyhydroxide in African American dialysis patients.
Academic Article	Should phosphate management be limited to the KDIGO/ KDOQI guidelines?
Academic Article	Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 Study.
Academic Article	A safety evaluation of sucroferric oxyhydroxide for the treatment of hyperphosphatemia.
Academic Article	Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidence.
Academic Article	Managing Phosphate Burden in Patients Receiving Dialysis: Beyond Phosphate Binders and Diet.
Academic Article	Serum Phosphorus Management with Sucroferric Oxyhydroxide as a First-Line Phosphate Binder within the First Year of Hemodialysis.
Academic Article	Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.

Search Criteria

Dialysis